23andMe has been testing the waters for a buyer for Lemonaid Health, the virtual-care business it bought in 2021 for $400 million in cash and stock, people with knowledge of the efforts told BI.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback